Matches in SemOpenAlex for { <https://semopenalex.org/work/W2196188512> ?p ?o ?g. }
- W2196188512 endingPage "648" @default.
- W2196188512 startingPage "639" @default.
- W2196188512 abstract "Antibody therapeutic targeting of the immune checkpoints cytotoxic T-lymphocyte-associated molecule 4 (CTLA-4) and programmed cell death 1 (PD-1) has demonstrated marked tumor regression in clinical trials. MicroRNAs (miRNAs) can modulate multiple gene transcripts including possibly more than one immune checkpoint and could be exploited as immune therapeutics.Using online miRNA targeting prediction algorithms, we searched for miRNAs that were predicted to target both PD-1 and CTLA-4. MiR-138 emerged as a leading candidate. The effects of miR-138 on CTLA-4 and PD-1 expression and function in T cells were determined and the therapeutic effect of intravenous administration of miR-138 was investigated in both immune-competent and -incompetent murine models of GL261 glioma.Target binding algorithms predicted that miR-138 could bind the 3' untranslated regions of CTLA-4 and PD-1, which was confirmed with luciferase expression assays. Transfection of human CD4+ T cells with miR-138 suppressed expression of CTLA-4, PD-1, and Forkhead box protein 3 (FoxP3) in transfected human CD4+ T cells. In vivo miR-138 treatment of GL261 gliomas in immune-competent mice demonstrated marked tumor regression, a 43% increase in median survival time (P = .011), and an associated decrease in intratumoral FoxP3+ regulatory T cells, CTLA-4, and PD-1 expression. This treatment effect was lost in nude immune-incompetent mice and with depletion of CD4+ or CD8+ T cells, and miR-138 had no suppressive effect on glioma cells when treated directly at physiological in vivo doses.MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints which may have rapid translational potential as a novel immunotherapeutic agent." @default.
- W2196188512 created "2016-06-24" @default.
- W2196188512 creator A5012278399 @default.
- W2196188512 creator A5012403937 @default.
- W2196188512 creator A5013938672 @default.
- W2196188512 creator A5030122856 @default.
- W2196188512 creator A5038172006 @default.
- W2196188512 creator A5044032746 @default.
- W2196188512 creator A5045984402 @default.
- W2196188512 creator A5064627876 @default.
- W2196188512 creator A5066544434 @default.
- W2196188512 creator A5076390925 @default.
- W2196188512 creator A5079081497 @default.
- W2196188512 creator A5082498438 @default.
- W2196188512 creator A5083530750 @default.
- W2196188512 creator A5086792863 @default.
- W2196188512 creator A5087778827 @default.
- W2196188512 creator A5088821817 @default.
- W2196188512 date "2015-12-11" @default.
- W2196188512 modified "2023-10-14" @default.
- W2196188512 title "MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints" @default.
- W2196188512 cites W144423133 @default.
- W2196188512 cites W1530763983 @default.
- W2196188512 cites W1632989995 @default.
- W2196188512 cites W1815157104 @default.
- W2196188512 cites W182346121 @default.
- W2196188512 cites W1891618255 @default.
- W2196188512 cites W1974223688 @default.
- W2196188512 cites W1996044457 @default.
- W2196188512 cites W2003119703 @default.
- W2196188512 cites W2010121426 @default.
- W2196188512 cites W2013090484 @default.
- W2196188512 cites W2014364806 @default.
- W2196188512 cites W2014730095 @default.
- W2196188512 cites W2036044314 @default.
- W2196188512 cites W2047230902 @default.
- W2196188512 cites W2071011329 @default.
- W2196188512 cites W2074679319 @default.
- W2196188512 cites W2080789936 @default.
- W2196188512 cites W2096287682 @default.
- W2196188512 cites W2097995306 @default.
- W2196188512 cites W2102348612 @default.
- W2196188512 cites W2104610341 @default.
- W2196188512 cites W2107731685 @default.
- W2196188512 cites W2112601576 @default.
- W2196188512 cites W2112936527 @default.
- W2196188512 cites W2114701172 @default.
- W2196188512 cites W2114850139 @default.
- W2196188512 cites W2118503880 @default.
- W2196188512 cites W2120426749 @default.
- W2196188512 cites W2120821369 @default.
- W2196188512 cites W2124199305 @default.
- W2196188512 cites W2128078546 @default.
- W2196188512 cites W2131577873 @default.
- W2196188512 cites W2140521865 @default.
- W2196188512 cites W2141756397 @default.
- W2196188512 cites W2143163879 @default.
- W2196188512 cites W2144753743 @default.
- W2196188512 cites W2149387197 @default.
- W2196188512 cites W2154116432 @default.
- W2196188512 cites W2155101465 @default.
- W2196188512 cites W2155262772 @default.
- W2196188512 cites W2160834915 @default.
- W2196188512 cites W2313466666 @default.
- W2196188512 cites W2560367415 @default.
- W2196188512 cites W2572174216 @default.
- W2196188512 cites W2602291171 @default.
- W2196188512 doi "https://doi.org/10.1093/neuonc/nov292" @default.
- W2196188512 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4827047" @default.
- W2196188512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26658052" @default.
- W2196188512 hasPublicationYear "2015" @default.
- W2196188512 type Work @default.
- W2196188512 sameAs 2196188512 @default.
- W2196188512 citedByCount "155" @default.
- W2196188512 countsByYear W21961885122016 @default.
- W2196188512 countsByYear W21961885122017 @default.
- W2196188512 countsByYear W21961885122018 @default.
- W2196188512 countsByYear W21961885122019 @default.
- W2196188512 countsByYear W21961885122020 @default.
- W2196188512 countsByYear W21961885122021 @default.
- W2196188512 countsByYear W21961885122022 @default.
- W2196188512 countsByYear W21961885122023 @default.
- W2196188512 crossrefType "journal-article" @default.
- W2196188512 hasAuthorship W2196188512A5012278399 @default.
- W2196188512 hasAuthorship W2196188512A5012403937 @default.
- W2196188512 hasAuthorship W2196188512A5013938672 @default.
- W2196188512 hasAuthorship W2196188512A5030122856 @default.
- W2196188512 hasAuthorship W2196188512A5038172006 @default.
- W2196188512 hasAuthorship W2196188512A5044032746 @default.
- W2196188512 hasAuthorship W2196188512A5045984402 @default.
- W2196188512 hasAuthorship W2196188512A5064627876 @default.
- W2196188512 hasAuthorship W2196188512A5066544434 @default.
- W2196188512 hasAuthorship W2196188512A5076390925 @default.
- W2196188512 hasAuthorship W2196188512A5079081497 @default.
- W2196188512 hasAuthorship W2196188512A5082498438 @default.
- W2196188512 hasAuthorship W2196188512A5083530750 @default.
- W2196188512 hasAuthorship W2196188512A5086792863 @default.
- W2196188512 hasAuthorship W2196188512A5087778827 @default.